Ivabradine is indicated to reduce the risk of hospitalisation for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection ...

Please provide your email address to receive an email when new articles are posted on . Initiating ivabradine before discharge among patients with stabilized HF increased ivabradine use at 180 days ...

Review the side-effects of Ivabradine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

The heart failure drug ivabradine (Corlanor) can provide relief from the elevated heart rate and often debilitating symptoms associated with postural orthostatic tachycardia syndrome (POTS), a new ...

SILVER SPRING, MD — Response to the recent approval of the heart-rate–slowing drug ivabradine (Corlanor, Amgen) by the US Food and Drug Administration (FDA) has included cautious enthusiasm as well as ...

Here, we report the case of a 54-year-old man with an inoperable metastatic paraganglioma in whom systemic targeted radiotherapy with 177 Lu-Dotatate was indicated. He had hypertension and tachycardia ...

Ivabradine is a novel agent that lowers heart rate by inhibiting the I(f) current in the sinoatrial node. The SHIFT trial evaluated the drug’s efficacy in 6,558 patients with symptomatic chronic heart ...

Sacubitril/valsartan and ivabradine are drugs that help in the treatment of severe heart failure through different mechanisms. They reduce the need for hospitalizations due to heart failure They have ...

Ivabradine (Procoralan, Servier Laboratories) is a heart-rate-lowering agent that selectively and specifically inhibits the cardiac pacemaker If current, which controls the spontaneous diastolic ...

The manufacturer conducted a systematic literature search and identified only 1 randomised controlled trial that assessed the effect of ivabradine in people with heart failure, known as SHIFT ...